tiprankstipranks
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market
Want to see AU:RCE full AI Analyst Report?

Recce Pharmaceuticals Ltd. (RCE) Financial Statements

22 Followers

Recce Pharmaceuticals Ltd. Financial Overview

Recce Pharmaceuticals Ltd.'s market cap is currently AU$113.13M. The company's EPS TTM is AU$-0.0518; its P/E ratio is -7.14; Recce Pharmaceuticals Ltd. is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 7.51MAU$ 5.03MAU$ 4.37MAU$ 3.08M
Gross ProfitAU$ -356.40KAU$ -2.94MAU$ -2.19MAU$ 4.15MAU$ 2.90M
Operating IncomeAU$ -23.16MAU$ -22.88MAU$ -22.05MAU$ -17.33MAU$ -14.15M
EBITDAAU$ -22.81MAU$ -20.33MAU$ -21.35MAU$ -16.99MAU$ -13.87M
Net IncomeAU$ -14.96MAU$ -21.43MAU$ -17.66MAU$ -13.08MAU$ -10.99M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 2.69MAU$ 10.45MAU$ 4.42MAU$ 1.56MAU$ 11.58M
Total AssetsAU$ 8.53MAU$ 12.41MAU$ 6.37MAU$ 2.56MAU$ 12.62M
Total DebtAU$ 10.44MAU$ 10.77MAU$ 811.19KAU$ 250.57KAU$ 74.76K
Net DebtAU$ 7.75MAU$ 319.44KAU$ -3.60MAU$ -1.31MAU$ -11.51M
Total LiabilitiesAU$ 25.25MAU$ 15.47MAU$ 15.89MAU$ 5.14MAU$ 2.56M
Stockholders' EquityAU$ -16.72MAU$ -3.05MAU$ -9.52MAU$ -2.59MAU$ 10.06M
Cash Flow
Free Cash FlowAU$ -9.95MAU$ -20.47MAU$ -13.15MAU$ -12.73MAU$ -9.05M
Operating Cash FlowAU$ -9.89MAU$ -20.44MAU$ -13.01MAU$ -12.69MAU$ -9.01M
Investing Cash FlowAU$ 123.60KAU$ -443.90KAU$ -141.90KAU$ -38.63KAU$ -40.34K
Financing Cash FlowAU$ 2.01MAU$ 26.92MAU$ 16.00MAU$ 2.71MAU$ -240.50K
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

Recce Pharmaceuticals Ltd. Debt to Assets

Recce Pharmaceuticals Ltd. Cash Flow

Recce Pharmaceuticals Ltd. Forecast EPS vs Actual EPS